Tag: FDA

2 new FDA indications March 2017

The FDA approved one new drug and gave a new indication for a previously approved drug in March 2017. The FDA approved a new drug, called ribociclib for use in metastatic hormone-positive breast cancer. Ribociclib is a pill that inhibits CDK 4/6 similar to a previously approved drug, palbociclib, that we wrote about previously. http://www.hoaallc.com/palbociclib-and-hormonal-therapy-has-proven-progression-free-survival-benefit/… Read more »